93 related articles for article (PubMed ID: 8983071)
1. Analysis of molecular functions of the tumor metastasis promoting surface molecule CD44v4-v7 using transgenic mice.
Moll J; Sleeman J; Kondo K; Hekele A; Plug R; Sherman L; Ponta H; Herrlich P; Schmidt A; Zöller M
Princess Takamatsu Symp; 1994; 24():142-51. PubMed ID: 8983071
[TBL] [Abstract][Full Text] [Related]
2. Accelerated immune response in transgenic mice expressing rat CD44v4-v7 on T cells.
Moll J; Schmidt A; van der Putten H; Plug R; Ponta H; Herrlich P; Zöller M
J Immunol; 1996 Mar; 156(6):2085-94. PubMed ID: 8690896
[TBL] [Abstract][Full Text] [Related]
3. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
Welsh CF; Zhu D; Bourguignon LY
J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
[TBL] [Abstract][Full Text] [Related]
4. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
5. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.
Galluzzo E; Albi N; Fiorucci S; Merigiola C; Ruggeri L; Tosti A; Grossi CE; Velardi A
Eur J Immunol; 1995 Oct; 25(10):2932-9. PubMed ID: 7589094
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of CD44 variant (v10/ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis.
Iida N; Bourguignon LY
J Cell Physiol; 1997 May; 171(2):152-60. PubMed ID: 9130462
[TBL] [Abstract][Full Text] [Related]
7. CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance.
Klingbeil P; Marhaba R; Jung T; Kirmse R; Ludwig T; Zöller M
Mol Cancer Res; 2009 Feb; 7(2):168-79. PubMed ID: 19208744
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
Abetamann V; Kern HF; Elsässer HP
Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
[TBL] [Abstract][Full Text] [Related]
9. CD44 isoforms in metastatic cancer.
Ponta H; Sleeman J; Dall P; Moll J; Sherman L; Herrlich P
Invasion Metastasis; 1994-1995; 14(1-6):82-6. PubMed ID: 7544777
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
Fichtner I; Dehmel A; Naundorf H; Finke LH
Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216
[TBL] [Abstract][Full Text] [Related]
11. The variant mRNA isoform of human metastasis gene (CD44V) detected in the cell lines of human hepatocellular carcinoma.
Harn HJ; Ho LI; Yu CP; Wang MW; Lee HS; Lin JJ; Lee WH; Isola NR; Cooper DL
Biochem Mol Biol Int; 1994 Feb; 32(2):233-8. PubMed ID: 7517252
[TBL] [Abstract][Full Text] [Related]
12. CD44v6 promotes proliferation by persisting activation of MAP kinases.
Marhaba R; Bourouba M; Zöller M
Cell Signal; 2005 Aug; 17(8):961-73. PubMed ID: 15894169
[TBL] [Abstract][Full Text] [Related]
13. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.
Hofmann M; Rudy W; Günthert U; Zimmer SG; Zawadzki V; Zöller M; Lichtner RB; Herrlich P; Ponta H
Cancer Res; 1993 Apr; 53(7):1516-21. PubMed ID: 8453616
[TBL] [Abstract][Full Text] [Related]
14. The CD44 receptor of the mouse LB T-cell lymphoma: analysis of the isoform repertoire and ligand binding properties by reverse-transcriptase polymerase chain reaction and antisense oligonucleotides.
Wallach SB; Friedmann A; Naor D
Cancer Detect Prev; 2000; 24(1):33-45. PubMed ID: 10757121
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD44 variant isoforms in malignant melanoma.
Seiter S; Schadendorf D; Herrmann K; Schneider M; Rösel M; Arch R; Tilgen W; Zöller M
Clin Cancer Res; 1996 Mar; 2(3):447-56. PubMed ID: 9816190
[TBL] [Abstract][Full Text] [Related]
16. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells.
Bourguignon LY; Zhu H; Shao L; Zhu D; Chen YW
Cell Motil Cytoskeleton; 1999; 43(4):269-87. PubMed ID: 10423269
[TBL] [Abstract][Full Text] [Related]
17. CD44 promotes progenitor homing into the thymus and T cell maturation.
Rajasagi M; Vitacolonna M; Benjak B; Marhaba R; Zöller M
J Leukoc Biol; 2009 Feb; 85(2):251-61. PubMed ID: 18955544
[TBL] [Abstract][Full Text] [Related]
18. Alternatively spliced CD44 isoforms containing exon v10 promote cellular adhesion through the recognition of chondroitin sulfate-modified CD44.
Chiu RK; Droll A; Dougherty ST; Carpenito C; Cooper DL; Dougherty GJ
Exp Cell Res; 1999 Apr; 248(1):314-21. PubMed ID: 10094837
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
[TBL] [Abstract][Full Text] [Related]
20. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P
Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
